Synaffix secures additional ADC technology licensing deals
January 6th, 2023 | 🕒
iSpeech.org First off, it inked a licensing agreement with Amgen to develop next generation ADCs. Amgen will gain access to
January 6th, 2023 | 🕒
iSpeech.org First off, it inked a licensing agreement with Amgen to develop next generation ADCs. Amgen will gain access to
December 15th, 2022 | 🕒
https://www.ispeech.org/text.to.speech The company said the license is an important milestone for the facility, which is located in northwestern France, continuing
September 8th, 2022 | 🕒
https://www.ispeech.org Under the terms of the agreement, Lonza can now provide its customers with seamless access to Touchlight’s enzymatic DNA
February 15th, 2022 | 🕒
iSpeech The company is aiming to bring to market an ultra-fast analysis platform capable of rapidly scaling to many diseases
January 17th, 2022 | 🕒
https://www.ispeech.org In that context, it is encouraging certain businesses that support the vaccine supply chain to engage with it. “If
June 20th, 2021 | 🕒
https://www.ispeech.orgNPD Gallery: Technology Insider BioPharma-Reporter.com Source link
Gloss